Form D · Venture Capital Fund

ACORN BIOVENTURES, L.P.

New York, NY · CIK 0001766853

Offering snapshot reported Mar 27, 2020 · SEC filing

Reported sold: $200M
Investors reported: 16
Minimum accepted: $0
First sale: Mar 7, 2019

What changed?

Latest filing versus its linked predecessor, where available.

Reported investors0 → 16

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Mar 27, 2020	Amendment	$199,500,000	No comparison	16	SEC filing
Mar 1, 2019	Initial	Yet to sell	No comparison	0	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06b, 3C, 3C.1, 3C.7
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-333917

Source: Form D, filed Mar 27, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

ACORN BIOVENTURES, L.P.

Investment adviser: ACORN CAPITAL ADVISORS, LLC

Gross asset value: $160M
Beneficial owners: 18
ADV minimum commitment: $1M

Reported in Form ADV on Mar 19, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator ALTER DOMUS LLC BOSTON, Massachusetts, United States Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor CBIZ, INC. NEW YORK, New York, United States

Custodian PERSHING LLC JERSEY CITY, New Jersey, United States Related to adviser: No

Prime broker MAREX CAPITAL MARKETS INC. NEW YORK, New York, United States

Provider details

Annual audit: Yes
Prime brokers: Yes
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: No

CBIZ, INC.
PCAOB 199

PERSHING LLC
SEC 8-17574

MAREX CAPITAL MARKETS INC.
CRD 161014 · SEC 8-69039

Filing source

Form ADV 2046701 · Mar 19, 2026 · Schedule D 7.B.(1), fund 805-1603524425

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

Related funds

Funds whose names form a numbered series with this one and that share its city or the name of a related person. Form D does not state how these funds are related.

Fund	Latest Form D	Reported sold	Investors
ACORN BIOVENTURES, L.P. (this fund)	Mar 27, 2020	$199,500,000	16
ACORN BIOVENTURES 2, L.P.	Dec 2, 2021	Yet to sell	0

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
General Partner Acorn Capital Advisors Gp, Llc	Promoter

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

420 Lexington Avenue, Suite 2626
New York, NY, 10170